HYFT

MindWalk Holdings Corp.

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-529.5K
ExitQ1 2026
$529k
--
$1.79
Jim SimonsRenaissance Technologies
$263k232.5k shares
TrimQ1 2026
$172k
$1.13
$1.79
Jim SimonsRenaissance Technologies
$435k239.1k shares
AddQ4 2025
$49k
$1.82
$1.79

News

businesswire.comMindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discoverybusinesswire.comJun 12businesswire.comMindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discoverybusinesswire.comJun 10gurufocus.comMindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypegurufocus.comJun 2businesswire.comMindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaignsbusinesswire.comJun 2businesswire.comMindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coveragebusinesswire.comMay 27